A detailed history of Financial Advocates Investment Management transactions in Stryker Corp stock. As of the latest transaction made, Financial Advocates Investment Management holds 4,091 shares of SYK stock, worth $1.47 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,091
Previous 4,088 0.07%
Holding current value
$1.47 Million
Previous $1.39 Million 6.26%
% of portfolio
0.08%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$315.94 - $371.96 $947 - $1,115
3 Added 0.07%
4,091 $1.48 Million
Q2 2024

Jul 26, 2024

SELL
$324.3 - $354.67 $13,944 - $15,250
-43 Reduced 1.04%
4,088 $1.39 Million
Q1 2024

May 01, 2024

SELL
$293.94 - $358.71 $48,206 - $58,828
-164 Reduced 3.82%
4,131 $1.48 Million
Q4 2023

Feb 08, 2024

SELL
$253.85 - $299.46 $317,566 - $374,624
-1,251 Reduced 22.56%
4,295 $1.29 Million
Q3 2023

Oct 27, 2023

SELL
$266.54 - $302.43 $10,661 - $12,097
-40 Reduced 0.72%
5,546 $1.52 Million
Q2 2023

Aug 07, 2023

BUY
$271.49 - $305.09 $11,674 - $13,118
43 Added 0.78%
5,586 $1.7 Million
Q1 2023

May 11, 2023

BUY
$246.13 - $285.47 $194,442 - $225,521
790 Added 16.62%
5,543 $1.58 Million
Q4 2022

Feb 14, 2023

BUY
$205.51 - $253.93 $69,256 - $85,574
337 Added 7.63%
4,753 $1.16 Million
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $27,065 - $33,151
143 Added 3.35%
4,416 $770,000
Q2 2022

Aug 12, 2022

SELL
$194.09 - $276.37 $15,333 - $21,833
-79 Reduced 1.82%
4,273 $850,000
Q1 2022

May 11, 2022

SELL
$245.33 - $277.77 $23,306 - $26,388
-95 Reduced 2.14%
4,352 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$236.63 - $276.44 $272,124 - $317,906
1,150 Added 34.88%
4,447 $1.19 Million
Q3 2021

Nov 04, 2021

BUY
$248.9 - $280.09 $33,601 - $37,812
135 Added 4.27%
3,297 $869,000
Q2 2021

Aug 03, 2021

SELL
$242.95 - $267.0 $18,950 - $20,826
-78 Reduced 2.41%
3,162 $821,000
Q1 2021

May 10, 2021

SELL
$221.01 - $248.82 $28,510 - $32,097
-129 Reduced 3.83%
3,240 $789,000
Q4 2020

Feb 12, 2021

SELL
$202.01 - $245.04 $50,502 - $61,260
-250 Reduced 6.91%
3,369 $825,000
Q3 2020

Nov 04, 2020

BUY
$177.77 - $215.81 $41,420 - $50,283
233 Added 6.88%
3,619 $754,000
Q2 2020

Aug 14, 2020

BUY
$144.67 - $207.03 $190,675 - $272,865
1,318 Added 63.73%
3,386 $610,000
Q1 2020

Apr 29, 2020

BUY
$126.5 - $225.1 $126 - $225
1 Added 0.05%
2,068 $344,000
Q4 2019

Feb 13, 2020

BUY
$197.98 - $220.53 $197 - $220
1 Added 0.05%
2,067 $434,000
Q3 2019

Nov 13, 2019

SELL
$205.4 - $221.82 $20,334 - $21,960
-99 Reduced 4.57%
2,066 $447,000
Q2 2019

Aug 08, 2019

SELL
$180.24 - $205.58 $8,831 - $10,073
-49 Reduced 2.21%
2,165 $445,000
Q1 2019

May 16, 2019

BUY
$152.46 - $198.0 $7,623 - $9,900
50 Added 2.31%
2,214 $437,000
Q4 2018

Feb 14, 2019

BUY
$145.0 - $178.65 $35,235 - $43,411
243 Added 12.65%
2,164 $339,000
Q3 2018

Nov 14, 2018

SELL
$163.25 - $177.68 $1,469 - $1,599
-9 Reduced 0.47%
1,921 $0
Q2 2018

Aug 09, 2018

SELL
$155.17 - $179.78 $93,412 - $108,227
-602 Reduced 23.78%
1,930 $328,000
Q1 2018

May 11, 2018

BUY
$148.01 - $168.91 $444 - $506
3 Added 0.12%
2,532 $407,000
Q4 2017

Feb 15, 2018

BUY
$143.51 - $159.74 $362,936 - $403,982
2,529
2,529 $391,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.